Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-04-21, Stock:LLY, The news for the past five days is as follows:
2020-04-14: NEWS1: Indexes Near Session Highs As These Top Stocks Finally Clear Buy Points.NEWS2: Eli Lilly Surges to a New High and a New Price Target Opens Up.NEWS3: SNY vs. LLY: Which Stock Is the Better Value Option?.NEWS4: Potential new treatment for COVID-19 uncovered by BenevolentAI enters trials.NEWS5: PRESS DIGEST- New York Times business news - April 14.
2020-04-15: NEWS1: Eli Lilly (LLY) Gains As Market Dips: What You Should Know.NEWS2: Pharma Q1 Earnings Begin With J&J's Report: 3 Stocks to Buy.NEWS3: Dow Jones Futures Fall But Tesla, Airlines Rise After Amazon Leads New Breakouts In Coronavirus Stock Market Rally.NEWS4: Buy 5 Top Stocks Set to Beat on Q1 Earnings This Month.NEWS5: Dow Jones Futures: Coronavirus Stock Market Rally Soars As Two Wrongs Go Right; Amazon, Nvidia Lead New Breakouts.
2020-04-16: NEWS1: Eli Lilly Still Within Buy Range As Quarterly Report Nears.NEWS2: Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?.NEWS3: Roche Most Innovative, Astra Zeneca Most Inventive.NEWS4: Lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® now available.
2020-04-17: NEWS1: In a Pandemic, Pharma’s Strengths Emerge: Pipelines With Essential Drugs.NEWS2: These experimental drugs may help keep COVID-19 patients off ventilators.NEWS3: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS4: Pharma Stock Roundup: JNJ's Q1 Earnings, Coronavirus Product Development Efforts.NEWS5: Drug trial specialists see coronavirus-fueled spike in demand for virtual services.
2020-04-20: NEWS1: Alexion Will Test Rare Disease Drug in Covid-19 Patients.NEWS2: The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Moderna, Sanofi, Vaxart and Eli Lilly.NEWS3: 5 Top Must-Buy Stocks Set to Beat on Q1 Earnings This Week.NEWS4: RPT-Drug trial specialists see coronavirus-fueled spike in demand for virtual services.

Answer: Decrease